Response of cftr-deficient mice to long-term chronic pseudomonas aeruginosa infection and PTX3 therapy

Journal of Infectious Diseases

Volumn 208, Issue 1, 2013, Pages 130-138

  Paroni, Moira ^a   Moalli, Federica ^d   Nebuloni, Manuela ^c   Pasqualini, Fabio ^d   Bonfield, Tracey ^f   Nonis, Alessandro ^b   Mantovani, Alberto ^d,e   Garlanda, Cecilia ^d   Bragonzi, Alessandra ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cystic Fibrosis; inflammation; Mouse Model; Pseudomonas Infection; PTX3; Respiratory Tract Infections

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PENTRAXIN 3; PLACEBO; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM COLONY; BODY WEIGHT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATION; MALE; MOUSE; MULTIDRUG RESISTANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS;

CYSTIC FIBROSIS; INFLAMMATION; MOUSE MODEL; PSEUDOMONAS INFECTION; PTX3; RESPIRATORY TRACT INFECTIONS;

ANIMALS; C-REACTIVE PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LUNG; MALE; MICE; MICE, INBRED CFTR; PHAGOCYTOSIS; PSEUDOMONAS INFECTIONS; RECOMBINANT PROTEINS; SERUM AMYLOID P-COMPONENT;

EID: 84878554715     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis636     Document Type: Article

References (28)

1. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008; 133:489-95.
2. Ratjen F. What's new in CF airway inflammation: an update. Paediatr Respir Rev 2006; 7:S70-2.
3. Bonfield T, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-8.
4. Bonfield T, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the antiinflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13:257-61.
5. Koehler D, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 2004; 31:377-81.
6. Lands L, Dauletbaev N. High-dose ibuprofen in cystic fibrosis. Pharmaceuticals 2010; 3:2213-24.
7. Mookherjee N, Hancock RE. Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007; 64:922-33.
8. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23:337-66.
9. Inforzato A, Jaillon S, Moalli F, et al. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. Tissue Antigens 2011; 4:271-82.
10. Deban L, Russo RC, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010; 11:328-34.
11. Garlanda C, Hirsch E, Bozza S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-6.
12. Chiarini M, Sabelli C, Melotti P, et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010; 11:665-70.
13. Moalli F, Paroni M, Véliz Rodriguez T, et al. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol 2011; 186:5425-34.
14. Bragonzi A. Murine models of acute and chronic lung infection with cystic fibrosis pathogens. IJMM 2010; 300:584-93.
15. Bragonzi A, Paroni M, Nonis A, et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. AJRCCM 2009; 180:138-45.
16. Bragonzi A, Wiehlmann L, Klockgether J, et al. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 2006; 152:3261-9.
17. Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997; 272:32817-23.
18. Rivieccio V, Esposito A, Bellofiore P, Palladino P, Sassano M, Colombo M. Verdoliva high-level expression and efficient purification of recombinant human long pentraxin PTX3 in Chinese hamster ovary cells. Protein Expr Purif 2007; 51:49-58.
19. van Heeckeren A, Schluchter MD, Drumm ML, Davis PB. Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287:L944-52.
20. Bragonzi A, Worlitzsch D, Pier GB, et al. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis 2005; 192:410-9.
21. Pier G, Thomas DM. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. J Infect Dis 1982; 145:217-23.
22. Moalli F, Doni A, Deban L, et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010; 116:5170-80.
23. Gaziano R, Bozza S, Bellocchio S, et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. Antimicrob Agents Chemother 2004; 11:4414-21.
24. van Heeckeren AM, Schluchter M, Xue W, Davis PB. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am J Respir Crit Care Med 2006; 173:288-96.
25. McMorran BJ, Palmer J, Lunn DP, et al. G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease. Am J Physiol Lung Cell Mol Physiol 2001; 281:740-7.
26. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204:793-804.
27. Chen C, Schaller-Bals S, Paul KP, Wahn U, Bals R. Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros 2004; 3:45-50.
28. Geert RMVP, Bracke KR, Pauwels NS, et al. Reduced expression of pentraxin-3 in the lungs of patients with COPD. Am J Respir Crit Care Med 2010; 181:A3887.